Clinical Trial Update: Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating matuzumab in combination with pemetrexed for advanced non-small cell lung cancer has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• matuzumab (matuzumab)

Snippet

Sponsor: EMD Serono | Conditions: Lung Cancer, Non Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-04-06